JuneBrain Inc. is a Baltimore medtech startup building a wearable, AI-powered eye-scanning system that brings optical coherence tomography (OCT) out of the eye clinic and into neurology, primary care, and the home. Its flagship Neuro-i SS-OCT captures high-resolution retinal images without a technician, and its AI software turns those images into quantitative biomarkers clinicians can use to monitor diseases like multiple sclerosis, Alzheimer's, and Parkinson's between visits. Founded in 2017 by neuroscientist Samantha Scott after her own diagnosis with a neuromuscular disorder, the company is a WBENC-certified women-owned business on track for FDA submission in 2026.
Samantha Scott, PhD is the founder and CEO of JuneBrain, a Baltimore medtech startup building the first wearable, technician-free retinal scanning system. Trained as a biomedical engineer at Stanford and USC, she is turning high-resolution eye imaging plus AI into a way to detect and monitor brain and eye conditions far outside the walls of a clinic. JuneBrain has raised more than $3 million in private capital, won $3 million in NSF grants, holds four issued patents, and is on track for an FDA submission.
Intalight is a US-based ophthalmic imaging company (the international brand of SVision Imaging / 视微影像, Luoyang, China) that builds high-speed swept-source OCT and OCT-angiography systems. Its flagship DREAM OCT platform images the whole eye in a single ultra-widefield scan, combining deep retinal penetration, anterior-segment imaging, biometry, and AI-driven segmentation for clinicians and researchers worldwide.